Petalion Therapeutics

Petalion Therapeutics develops novel targeted dendrimer drug conjugates for unmet medical needs

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Petalion Therapeutics develops novel targeted dendrimer drug conjugates for unmet medical needs.

02Backed By1 investor

03Similar Companies

A

Adcytherix

Biotech & Life Sciences

→

T

A

CT

ST

04Startup DNA

6

signals

Sectors
Business Model
Technology